Signal Transduction and Targeted Therapy (Apr 2022)

Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

  • Qi Zhang,
  • Bridget Riley-Gillis,
  • Lina Han,
  • Yannan Jia,
  • Alessia Lodi,
  • Haijiao Zhang,
  • Saravanan Ganesan,
  • Rongqing Pan,
  • Sergej N. Konoplev,
  • Shannon R. Sweeney,
  • Jeremy A. Ryan,
  • Yulia Jitkova,
  • Kenneth Dunner,
  • Shaun E. Grosskurth,
  • Priyanka Vijay,
  • Sujana Ghosh,
  • Charles Lu,
  • Wencai Ma,
  • Stephen Kurtz,
  • Vivian R. Ruvolo,
  • Helen Ma,
  • Connie C. Weng,
  • Cassandra L. Ramage,
  • Natalia Baran,
  • Ce Shi,
  • Tianyu Cai,
  • Richard Eric Davis,
  • Venkata L. Battula,
  • Yingchang Mi,
  • Jing Wang,
  • Courtney D. DiNardo,
  • Michael Andreeff,
  • Jeffery W. Tyner,
  • Aaron Schimmer,
  • Anthony Letai,
  • Rose Ann Padua,
  • Carlos E. Bueso-Ramos,
  • Stefano Tiziani,
  • Joel Leverson,
  • Relja Popovic,
  • Marina Konopleva

DOI
https://doi.org/10.1038/s41392-022-00958-4
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 1

Abstract

Read online

No abstracts available.